Volume 34, Issue 10 (12-2023)                   Studies in Medical Sciences 2023, 34(10): 651-660 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Khalife Nezhad M, Lotfollahi Hagghi L, Abbasi Eslamloo A, Gheibi S, Esmaeili A. EVALUATION OF ANTIBIOTIC RESISTANCE PATTERNS IN PATIENTS ADMITTED TO INTENSIVE CARE UNITS OF IMAM KHOMEINI TEACHING HOSPITALS, URMIA. Studies in Medical Sciences 2023; 34 (10) :651-660
URL: http://umj.umsu.ac.ir/article-1-5959-en.html
Assistant Professor, Department of clinical pharmacy, school of pharmacy, Urmia University of Medical Sciences , ph.a.esmaeili@gmail.com
Abstract:   (1460 Views)
Background & Aim: The increasing prevalence of antibiotic resistance is a major health problem. The present study was designed and implemented to evaluate antibiotic resistance patterns in the patients admitted to Intensive Care Units of Imam Khomeini hospital in Urmia from September 2020 to September 2021.
Material & Methods: In this descriptive-cross-sectional study that was conducted from September 2020 to September 2021, all cell cultures of blood, urine, sputum and respiratory secretions, cerebrospinal fluid (CSF), synovial fluid, and peritoneal fluid of the patients admitted to the ICU of Imam Khomeini Hospital in Urmia were analyzed by a complete counting method.
the descriptive cross-sectional study over September 2020 till September 2021, through systemic sampling, all bacterial cultures of blood, urine, sputum and respiratory secretions, cerebrospinal fluid, synovial fluid, peritoneal fluid of the patients admitted in the ICU of imam Khomeini hospital were evaluated. Statistical analysis was conducted by SPSS 22. The significance level in this study was considered less than 0.05.
Results: In this study, a total of 1862 culture mediums were examined, of which 1162 mediums (62.4%) had negative cultures. Also, in 348 mediums (18.60%), there were mixed fungi or bacteria. Also, 22 samples were excluded from the study due to incomplete antibiogram reporting. Finally, 330 mediums were examined with the specific result of the type of bacteria grown to check microbial resistance. The most common microorganisms isolated from urine, blood, and sputum cultures were Escherichia coli, Klebsiella, and Acinetobacter, respectively. Out of 34 mediums belonging to Staphylococcus aureus, one case was resistant to methicillin and three cases were resistant to cephalexin. Out of 252 mediums belonging to Gram-negative bacteria, ESBL, MDR, PDR and XDR were present in 61.5%, 88.1%, 34.5% and 11.5%, respectively. Antibiogram was used in 314 cases (98.5%) and did not match in 16 cases (1.5%).
Conclusion: The present study shows the risk of increasing microbial resistance, exposure to treatment-resistant strains, and the risk of non-response to antibiotic treatment in the patients. Therefore, necessary managements should be taken to prevent the unreasonable prescription of antibiotics and the intensification of the resistance process.

 
Full-Text [PDF 391 kb]   (771 Downloads)    
Type of Study: Research | Subject: داروسازی

References
1. Siegel JD, Rhinehart E, Jackson M, Chiarello L. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 2007;35(10):S65-S164. [DOI:10.1016/j.ajic.2007.10.007] [PMID] []
2. Siegel JD, Rhinehart E, Jackson M, Chiarello L. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control 2007;35(10):S165-S93. [DOI:10.1016/j.ajic.2007.10.006] [PMID]
3. MacVane SH. Antimicrobial resistance in the intensive care unit: a focus on gram-negative bacterial infections. J Intensive Care Med 2017;32(1):25-37. [DOI:10.1177/0885066615619895] [PMID]
4. Frattari A, Savini V, Polilli E, Di Marco G, Lucisano G, Corridoni S, et al. Control of Gram-negative multi-drug resistant microorganisms in an Italian ICU: Rapid decline as a result of a multifaceted intervention, including conservative use of antibiotics. Int J Infect Dis 2019;84:153-62. [DOI:10.1016/j.ijid.2019.04.002] [PMID]
5. Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Aguilar GR, Gray A, Han C, Bisignano C, Rao P, Wool E, Johnson SC. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 2022;399(10325):629-55. [DOI:10.1016/S0140-6736(21)02724-0] [PMID]
6. Rasool MH, Zaheer M, Hassan MF, Shafique M, Qamar MU. Isolation and Antimicrobial Susceptibility Paradigm of Carbapenem Resistant Metallo-Beta-Lactamase Producing Gram Negative Rods. Pak J Zool 2019;51(3):849. [DOI:10.17582/journal.pjz/2019.51.3.849.854]
7. Capsoni N, Bellone P, Aliberti S, Sotgiu G, Pavanello D, Visintin B, et al. Prevalence, risk factors and outcomes of patients coming from the community with sepsis due to multidrug resistant bacteria. Multidiscip Respir Med 2019;14:1-11. [DOI:10.1186/s40248-019-0185-4] [PMID] []
8. Hemmati A, Nikoonejad A, Lotfollahi L, Jahed S, Nejadrahim R, Nabizadeh E, et al. Antibiotical Resistance Pattern of Microorganisms Isolated From Positive Blood Cultures At Icus of Imam Khomeini Hospital. Stud Med Sci 2016;27(6):533-40. [Google Scholar]
9. Yousefipour M, Rasoulinejad M, Hadadi A, Esmailpour N, Abdollahi A, Jafari S, et al. Bacteria producing extended spectrum β-lactamases (ESBLs) in hospitalized patients: Prevalence, antimicrobial resistance pattern and its main determinants. Iran J Pathol 2019;14(1):61. [DOI:10.30699/ijp.14.1.61] [PMID] []
10. Organization WH. Antimicrobial resistance: global report on surveillance: World Health Organization; 2014. [Google Scholar]
11. David MZ, Dryden M, Gottlieb T, Tattevin P, Gould IM. Recently approved antibacterials for methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive pathogens: the shock of the new. Int J Antimicrob Agents 2017;50(3):303-7. [DOI:10.1016/j.ijantimicag.2017.05.006] [PMID]
12. Sanchez GV, Babiker A, Master RN, Luu T, Mathur A, Bordon J. Antibiotic Resistance among Urinary Isolates from Female Outpatients in the United States in 2003 and 2012. Antimicrob Agents Chemother 2016;60(5):2680-3. [DOI:10.1128/AAC.02897-15] [PMID] []
13. Mandal J, Acharya NS, Buddhapriya D, Parija SC. Antibiotic resistance pattern among common bacterial uropathogens with a special reference to ciprofloxacin resistant Escherichia coli. Indian J Med Res 2012;136(5):842-9. [PMID]
14. Afkhamzadeh A, Lahoorpour F, Delpisheh A, Janmardi R. Incidence of ventilator- associated pneumonia (VAP) and bacterial resistance pattern in adult patients hospitalised at the intensive care unit of Besat Hospital in Sanandaj. Sci J Kurdistan Univ Med Sci 2011;16(1):20-6. [Google Scholar]
15. Mahmoudi H, Alikhani M Y, Arabestani M, Khosravi S. Evaluation Prevalence agents of urinary tract infection and antibiotic resistance in patients admitted to hospitals in Hamadan University of Medical Sciences 1391-92. Pajouhan Sci J 2014;12(3):20-7. [Google Scholar]
16. Zervos MJ, Hershberger E, Nicolau DP, Ritchie DJ, Blackner LK, Coyle EA, et al. Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000. Clin Infect Dis 2003;37(12):1643-8. [DOI:10.1086/379709] [PMID]
17. Ena J, Amador C, Martinez C, Ortiz de la Tabla V. Risk factors for acquisition of urinary tract infections caused by ciprofloxacin resistant Escherichia coli. J Urol 1995;153(1):117-20. [DOI:10.1097/00005392-199501000-00040] [PMID]
18. Moremi N, Mushi MF, Fidelis M, Chalya P, Mirambo M, Mshana SE. Predominance of multi-resistant gram-negative bacteria colonizing chronic lower limb ulcers (CLLUs) at Bugando Medical Center. BMC Res Notes 2014;7:211. [DOI:10.1186/1756-0500-7-211] [PMID] []
19. Shams F, Hasani A, Pormohammad A, Rezaee MA, Reza M, Nahaie AH, et al. qnrA implicated quinolone resistance in Escherichia coli and Klebsiella pneumoniae clinical isolates from a University Teaching Hospital. Life Sci J 2014;11(12s):1032-5. [Google Scholar]
20. Rezaee MA, Sheikhalizadeh V, Hasani A. Detection of integrons among multi-drug resistant (MDR) Escherichia coli strains isolated from clinical specimens in northern west of Iran. Braz J Microbiol 2011;42(4):1308-13. [DOI:10.1590/S1517-83822011000400010] [PMID] []
21. Salem MM, Magdy M, Alhosiny IM. Distribution of classes 1 and 2 integrons among multi drug resistant E. coli isolated from hospitalized patients with urinary tract infection in Cairo, Egypt. Aust J Basic Appl Sci 2010;4(3):398-407. [Google Scholar]
22. Kibret M, Abera B. Antimicrobial susceptibility patterns of E. coli from clinical sources in northeast Ethiopia. Afr Health Sci 2011;11 Suppl 1(Suppl 1):S40-5. [DOI:10.4314/ahs.v11i3.70069] [PMID] []
23. Sahm DF, Thornsberry C, Mayfield DC, Jones ME, Karlowsky JA. Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000. Antimicrob Agents Chemother 2001;45(5):1402-6. [DOI:10.1128/AAC.45.5.1402-1406.2001] [PMID] []

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Studies in Medical Sciences

Designed & Developed by : Yektaweb